Costin JM - Search Results

1

Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop.

Costin JM, Zaitseva E, Kahle KM, Nicholson CO, Rowe DK, Graham AS, Bazzone LE, Hogancamp G, Figueroa Sierra M, Fong RH, Yang ST, Lin L, Robinson JE, Doranz BJ, Chernomordik LV, Michael SF, Schieffelin JS, Isern S. Costin JM, et al. J Virol. 2013 Jan;87(1):52-66. doi: 10.1128/JVI.02273-12. Epub 2012 Oct 17. J Virol. 2013. PMID: 23077306 Free PMC article.

2

Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient.

Schieffelin JS, Costin JM, Nicholson CO, Orgeron NM, Fontaine KA, Isern S, Michael SF, Robinson JE. Schieffelin JS, et al. Among authors: costin jm. Virol J. 2010 Feb 4;7:28. doi: 10.1186/1743-422X-7-28. Virol J. 2010. PMID: 20132551 Free PMC article.

3

Viral entry inhibitors block dengue antibody-dependent enhancement in vitro.

Nicholson CO, Costin JM, Rowe DK, Lin L, Jenwitheesuk E, Samudrala R, Isern S, Michael SF. Nicholson CO, et al. Among authors: costin jm. Antiviral Res. 2011 Jan;89(1):71-4. doi: 10.1016/j.antiviral.2010.11.008. Epub 2010 Nov 18. Antiviral Res. 2011. PMID: 21093488

4

Release of dengue virus genome induced by a peptide inhibitor.

Lok SM, Costin JM, Hrobowski YM, Hoffmann AR, Rowe DK, Kukkaro P, Holdaway H, Chipman P, Fontaine KA, Holbrook MR, Garry RF, Kostyuchenko V, Wimley WC, Isern S, Rossmann MG, Michael SF. Lok SM, et al. Among authors: costin jm. PLoS One. 2012;7(11):e50995. doi: 10.1371/journal.pone.0050995. Epub 2012 Nov 30. PLoS One. 2012. PMID: 23226444 Free PMC article.

5

In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries.

Rees CR, Costin JM, Fink RC, McMichael M, Fontaine KA, Isern S, Michael SF. Rees CR, et al. Among authors: costin jm. Antiviral Res. 2008 Nov;80(2):135-42. doi: 10.1016/j.antiviral.2008.05.007. Epub 2008 Jun 13. Antiviral Res. 2008. PMID: 18606464

6

Structural optimization and de novo design of dengue virus entry inhibitory peptides.

Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF. Costin JM, et al. PLoS Negl Trop Dis. 2010 Jun 22;4(6):e721. doi: 10.1371/journal.pntd.0000721. PLoS Negl Trop Dis. 2010. PMID: 20582308 Free PMC article.

7

Cytopathic mechanisms of HIV-1.

Costin JM. Costin JM. Virol J. 2007 Oct 18;4:100. doi: 10.1186/1743-422X-4-100. Virol J. 2007. PMID: 17945027 Free PMC article. Review.

8

Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein.

Costin JM, Rausch JM, Garry RF, Wimley WC. Costin JM, et al. Virol J. 2007 Nov 20;4:123. doi: 10.1186/1743-422X-4-123. Virol J. 2007. PMID: 18028545 Free PMC article.

9

Concentration-dependent differential induction of necrosis or apoptosis by HIV-1 lytic peptide 1.

Plymale DR, Comardelle AM, Fermi CD, Martin DS, Costin JM, Norris CH, Tencza SB, Mietzner TA, Montelaro RC, Garry RF. Plymale DR, et al. Among authors: costin jm. Peptides. 1999 Nov;20(11):1275-83. doi: 10.1016/s0196-9781(99)00132-1. Peptides. 1999. PMID: 10612441

10

Human, rhesus macaque, and feline sequences highly similar to mouse mammary tumor virus sequences.

Szabo S, Haislip AM, Traina-Dorge V, Costin JM, Crawford BE 2nd, Wilson RB, Garry RF. Szabo S, et al. Among authors: costin jm. Microsc Res Tech. 2005 Nov;68(3-4):209-21. doi: 10.1002/jemt.20233. Microsc Res Tech. 2005. PMID: 16276510

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page